Lonza Optimized Protocol
Optimization Guideline
Filter:
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Categories:
Transfection
Authors:
Wang R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, Travisano KA, Hayashi
JM, Carlson-Stevermer J, Zengel JR, Richards CM, Fozouni P, Oki J,
Rodriguez L, Joehnk B, Walcott K, Holden K, Sil A, Carette JE, Krogan
NJ, Ott M, Puschnik AS
In:
Cell (2021) Jan 7;184(1): 106-119.e14.
Categories:
Primary Cells and Media, Transfection, Cell Lines and Primary Cancer Cells
Authors:
Christine Y.L. Tham, Janine Kah,
Anthony T. Tan, ..., Marc L€utgehetmann,
Maura Dandri, Antonio Bertoletti
In:
Cell Rep (2020) 1 (4): 100060
Categories:
Cell Lines and Primary Cancer Cells
Authors:
Markus Hoffmann 1 , Hannah Kleine-Weber 2 , Simon Schroeder 3 , Nadine Krüger 4 , Tanja Herrler 5 , Sandra Erichsen 6 , Tobias S Schiergens 7 , Georg Herrler 8 , Nai-Huei Wu 8 , Andreas Nitsche 9 , Marcel A Müller 10 , Christian Drosten 3 , Stefan Pöhlmann 11
In:
Cell (2020) 1: 1
Categories:
Transfection
Authors:
Hung JH, Lu YS, Wang YC, Ma YH, Wang DS, Kulp SK, Muthusamy N, Byrd JC, Cheng AL, Chen CS
In:
Cancer Res (2008) 68(4): 1204-12
Categories:
Transfection
Authors:
Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, Moriishi K, Fujiyama K, Kanto T, Hayashi N, Owsianka A, Patel AH, Whitt MA, Matsuura Y
In:
J Virol (2007) 81(16): 8601-12
Categories:
Transfection
Authors:
Cantarini MC, de la Monte SM, Pang M, Tong M, D'Errico A, Trevisani F, Wands JR
In:
Hepatology (2006) 44(2): 446-57